Pelvic exenteration: a retrospective study in a tertiary referral cancer center in the UK.

Autor:	Palaiologos K; Department of Obstetrics and Gynecology, Hull Royal Infirmary Hospital, Hull, UK - kostas_pal8@hotmail.com.; Hull University Teaching Hospitals NHS Trust, Hull, UK - kostas_pal8@hotmail.com., Karkia R; Academic Department of Gynecological Oncology, Royal Surrey NHS Foundation Trust, Guildford, UK., Nikoloudaki Z; Department of Obstetrics and Gynecology, Hull Royal Infirmary Hospital, Hull, UK.; Hull University Teaching Hospitals NHS Trust, Hull, UK., Mohamed A; Department of Obstetrics and Gynecology, Hull Royal Infirmary Hospital, Hull, UK.; Hull University Teaching Hospitals NHS Trust, Hull, UK., Lavelle R; Department of Obstetrics and Gynecology, Hull Royal Infirmary Hospital, Hull, UK.; Hull University Teaching Hospitals NHS Trust, Hull, UK., Booth S; Department of Obstetrics and Gynecology, Hull Royal Infirmary Hospital, Hull, UK.; Hull University Teaching Hospitals NHS Trust, Hull, UK., Flynn M; Department of Obstetrics and Gynecology, Hull Royal Infirmary Hospital, Hull, UK.; Hull University Teaching Hospitals NHS Trust, Hull, UK., Helbren C; Hull University Teaching Hospitals NHS Trust, Hull, UK.; Department of General Surgery, Hull Royal Infirmary Hospital, Hull, UK., Simms M; Hull University Teaching Hospitals NHS Trust, Hull, UK.; Department of Urology, Hull Royal Infirmary Hospital, Hull, UK., Giannopoulos T; Department of Obstetrics and Gynecology, Hull Royal Infirmary Hospital, Hull, UK.; Hull University Teaching Hospitals NHS Trust, Hull, UK.
Jazyk:	angličtina
Zdroj:	Minerva obstetrics and gynecology [Minerva Obstet Gynecol] 2024 Mar 27. Date of Electronic Publication: 2024 Mar 27.
DOI:	10.23736/S2724-606X.24.05337-5
Abstrakt:	Background: Pelvic exenteration (PE) is an extensive surgery that is indicated in cases of recurrent advanced gynecological cancer with curative and sometimes palliative intent. The procedure is associated with both high morbidity and mortality and as such is considered a highly specialist procedure. The aim of the study was to analyze surgical outcomes in women who underwent PE for advanced gynecological malignancy in a tertiary cancer referral center over 11 years. Methods: This is an observational retrospective single-center study. There were 17 patients included who underwent PE in Hull Royal Infirmary Hospital (Hull, UK) between 2010 and 2021. The main outcome measures were the perioperative complications, overall survival (OS), and recurrence free survival (RFS). Cumulative survival rates were reported at 1, 3 and 5 years. Univariate Cox regression analysis was undertaken to analyze factors that are prognostic for OS and RFS. Hazard Ratios (HR) with 95% confidence intervals (95% CI) were computed from the results of the Cox regression analyses. Kaplan-Meier survival curves were generated to visually display estimates of OS and RFS over the follow-up period. Results: The median age at the time of surgery was 63.0 (IQR: 48.0-71.0). All patients received surgery with curative intent and complete tumor resection (R0) was achieved in 94.1% of cases. An overall 5-year survival was achieved in 63.7% of patients. Mean overall survival (OS) was 8.4 years (95% CI: 7.78-9.02). The RFS was 5.0 years (95% CI: 4.13-5.87). Both OS and RFS were significantly negatively affected by the hospital stay (P=0.020 and P=0.035, respectively), but not by the type of surgery (P=0.263 and P=0.826, respectively). Conclusions: The results of the study demonstrated stable and comparable outcomes in patients undergoing pelvic exenteration.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu